However, whether the elevated MDSCs and CD68+CD163+M2-like macrophages promote tumor metastasis still needs a longer follow-up visit in NSCLC patients during radiotherapy and also deserves further investigations. The gene discussed is CD163; the disease is non-small cell lung carcinoma.